SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Celgene International Sárl Release: Results of Pivotal Study (MCL-001) Evaluating REVLIMID in Mantle-Cell Lymphoma Presented at 54th American Society of Hematology Annual Meeting